Pharmacological and Biochemical Evidence for the Existence of Two Categories of Dopamine Receptor
John W. Kebabian(National Institute of Neurological Disorders and Stroke), Yoshiharu Itoh(Kureha (Japan)), Jean‐Martin Beaulieu(University of Toronto)
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
February 1, 1984
Cited by 76
Related Papers
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
|Pharmacological Reviews|2011|2.7k
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
|Cell|2005|966
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
|Proceedings of the National Academy of Sciences|2004|786
Tryptophan Hydroxylase-2 Controls Brain Serotonin Synthesis
|Science|2004|685
Characterization of polysaccharides extracted from brown seaweeds
|Carbohydrate Polymers|2007|590